These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enterocyte proliferation and intestinal hyperplasia induced by simian virus 40 T antigen require a functional J domain. Rathi AV; Sáenz Robles MT; Pipas JM J Virol; 2007 Sep; 81(17):9481-9. PubMed ID: 17581980 [TBL] [Abstract][Full Text] [Related]
3. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Zalvide J; DeCaprio JA Mol Cell Biol; 1995 Oct; 15(10):5800-10. PubMed ID: 7565733 [TBL] [Abstract][Full Text] [Related]
4. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Wolf DA; Hermeking H; Albert T; Herzinger T; Kind P; Eick D Oncogene; 1995 Jun; 10(11):2067-78. PubMed ID: 7784051 [TBL] [Abstract][Full Text] [Related]
5. Simian virus 40 infection disrupts p130-E2F and p107-E2F complexes but does not perturb pRb-E2F complexes. Sullivan CS; Baker AE; Pipas JM Virology; 2004 Mar; 320(2):218-28. PubMed ID: 15016545 [TBL] [Abstract][Full Text] [Related]
6. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. O'Connor RJ; Schaley JE; Feeney G; Hearing P Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936 [TBL] [Abstract][Full Text] [Related]
7. Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. Markovics JA; Carroll PA; Robles MT; Pope H; Coopersmith CM; Pipas JM J Virol; 2005 Jun; 79(12):7492-502. PubMed ID: 15919904 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice. Chen Q; Liang D; Overbeek PA Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796 [TBL] [Abstract][Full Text] [Related]
9. Simian virus 40 T-antigen-mediated gene regulation in enterocytes is controlled primarily by the Rb-E2F pathway. Rathi AV; Sáenz Robles MT; Cantalupo PG; Whitehead RH; Pipas JM J Virol; 2009 Sep; 83(18):9521-31. PubMed ID: 19570859 [TBL] [Abstract][Full Text] [Related]
10. The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Sullivan CS; Cantalupo P; Pipas JM Mol Cell Biol; 2000 Sep; 20(17):6233-43. PubMed ID: 10938100 [TBL] [Abstract][Full Text] [Related]
11. Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs. Gupta T; Sáenz Robles MT; Pipas JM J Virol; 2015 May; 89(9):5124-33. PubMed ID: 25717106 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. Hu X; Cress WD; Zhong Q; Zuckerman KS Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571 [TBL] [Abstract][Full Text] [Related]
13. Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. Stubdal H; Zalvide J; DeCaprio JA J Virol; 1996 May; 70(5):2781-8. PubMed ID: 8627752 [TBL] [Abstract][Full Text] [Related]
14. Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Caracciolo V; Reiss K; Khalili K; De Falco G; Giordano A Oncogene; 2006 Aug; 25(38):5294-301. PubMed ID: 16936750 [TBL] [Abstract][Full Text] [Related]
15. The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Zalvide J; Stubdal H; DeCaprio JA Mol Cell Biol; 1998 Mar; 18(3):1408-15. PubMed ID: 9488456 [TBL] [Abstract][Full Text] [Related]
16. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors. Araki K; Kawauchi K; Tanaka N Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057 [TBL] [Abstract][Full Text] [Related]
17. Characterization of an E2F-p130 complex formed during growth arrest. Corbeil HB; Branton PE Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406 [TBL] [Abstract][Full Text] [Related]